These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28631027)

  • 1. Validation of a Liver Index and Its Significance for HCC Aggressiveness.
    Carr BI; Guerra V
    J Gastrointest Cancer; 2017 Sep; 48(3):262-266. PubMed ID: 28631027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Liver Index and its Relationship to Indices of HCC Aggressiveness.
    Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Rapaccini GL; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Masotto A; Trevisani F
    J Integr Oncol; 2016 Oct; 5(4):. PubMed ID: 28580457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Hepatocellular Carcinoma Aggressiveness Index and Its Relationship to Liver Enzyme Levels.
    Carr BI; Guerra V
    Oncology; 2016; 90(4):215-20. PubMed ID: 26974336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of platelet and AFP levels and liver function parameters for HCC size and survival.
    Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Rapaccini GL; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Int J Biol Markers; 2014 Sep; 29(3):e215-23. PubMed ID: 24526315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low alpha-fetoprotein HCC and the role of GGTP.
    Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Rapaccini GL; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F
    Int J Biol Markers; 2014 Dec; 29(4):e395-402. PubMed ID: 24832180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization.
    Ventura Y; Carr BI; Kori I; Guerra V; Shibolet O
    World J Gastroenterol; 2018 Apr; 24(15):1641-1649. PubMed ID: 29686471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients.
    Akkiz H; Carr BI; Yalçın K K; Guerra V; Kuran S; Altıntaş E; Üsküdar O; Karaoğullarından Ü; Özakyol A; Tokmak S; Yücesoy M; Bahçeci Hİ; Ülkü A; Akçam T; Yalçın Polat K; Ekinci N; Şimşek H; Örmeci N; Sonsuz A; Demir M; Kılıç M; Uygun A; Ballı T; Demir A; Arslan B; Doran F
    Oncology; 2018; 94(2):116-124. PubMed ID: 29207378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of gamma-glutamyl transpeptidase in relation to HCC human biology and prognosis.
    Carr BI; Akkiz H; Bag HG; Karaoğullarından U; Yalçın K; Ekin N; Özakyol A; Altıntaş E; Balaban HY; Şimşek H; Uyanıkoğlu A; Balkan A; Kuran S; Üsküdar O; Ülger Y; Güney B; Delik A
    J Transl Sci; 2021 Jun; 7(3):. PubMed ID: 34540270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum albumin levels in relation to tumor parameters in hepatocellular carcinoma patients.
    Carr BI; Guerra V
    Int J Biol Markers; 2017 Oct; 32(4):e391-e396. PubMed ID: 28862714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Features of massive hepatocellular carcinomas.
    Carr BI; Guerra V
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):101-8. PubMed ID: 23863262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-fetoprotein and albumin inversely relate to each other and to tumor parameters in patients with hepatocellular carcinoma.
    Carr B; Guerra V; Ince V; Isik B; Yilmaz S
    Hepatol Forum; 2024; 5(1):11-17. PubMed ID: 38283277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombocytopenia in relation to tumor size in patients with hepatocellular carcinoma.
    Carr BI; Guerra V; Pancoska P
    Oncology; 2012; 83(6):339-45. PubMed ID: 23006937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients.
    Carr BI; Giannelli G; Guerra V; Giannini EG; Farinati F; Rapaccini GL; Marco MD; Zoli M; Caturelli E; Masotto A; Virdone R; Sacco R; Trevisani F
    Int J Biol Markers; 2018 Nov; 33(4):423-431. PubMed ID: 29874983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macroscopic Portal Vein Thrombosis in HCC Patients.
    Akkiz H; Carr BI; Kuran S; Karaoğullarından Ü; Üsküdar O; Tokmak S; Arslan B; Doran F; Balli HT; Ülkü A; Akçam TA; Bahçeci Hİ; Polat KY; Örmeci N; Şimşek H; Sonsuz A; Demir A; Altıntaş E; Demir M; Yalçın K; Ekinci N; Harmancı Özakyol A; Yücesoy M; Uygun A; Guerra V; Delik A; Tokat Y; Yilmaz S; Bektaş A; Kılıç M
    Can J Gastroenterol Hepatol; 2018; 2018():3120185. PubMed ID: 30009156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors.
    Carr BI; Akkiz H; Guerra V; Üsküdar O; Kuran S; Karaoğullarından Ü; Tokmak S; Ballı T; Ülkü A; Akçam T; Delik A; Arslan B; Doran F; Yalçın K; Altntaş E; Özakyol A; Yücesoy M; Bahçeci Hİ; Polat KY; Ekinci N; Şimşek H; Örmeci N; Sonsuz A; Demir M; Kılıç M; Uygun A; Demir A; Yilmaz S; Tokat Y
    Clin Pract (Lond); 2018; 15(Spec Issue):625-634. PubMed ID: 29951199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of a unique gamma-glutamyl transpeptidase messenger RNA species closely related to the development of hepatocellular carcinoma in humans: a new candidate for early diagnosis of hepatocellular carcinoma.
    Tsutsumi M; Sakamuro D; Takada A; Zang SC; Furukawa T; Taniguchi N
    Hepatology; 1996 May; 23(5):1093-7. PubMed ID: 8621139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of increased serum GGTP levels in HCC patients.
    Carr BI; Pancoska P; Branch RA
    Hepatogastroenterology; 2010; 57(101):869-74. PubMed ID: 21033244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCC and its microenvironment.
    Carr BI; Guerra V
    Hepatogastroenterology; 2013 Sep; 60(126):1433-7. PubMed ID: 23933936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
    Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
    World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs.
    Carr BI; Guerra V; Donghia R; Farinati F; Giannini EG; Muratori L; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Sacco R; Celsa C; Campani C; Mega A; Guarino M; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Biasini E; Masotto A; Nardone G; Raimondo G; Azzaroli F; Vidili G; Brunetto MR; Trevisani F
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33546234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.